- Telehealth Visits
- Insurance plan information
Sarah Kim, MD
Diabetes • Pediatrics- Telehealth Visits
- Insurance plan information
Sarah Kim, MD
Diabetes • Pediatrics- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Endocrinology Diabetes & Metab, American Board of Internal Medicine
- Pediatrics, American Board of Pediatrics
Fellowship
- Endocrinology, UCSF Graduate Medical Education
- Endocrinology, University of California Los Angeles
Residency
- Internal Medicine & Pediatrics, University of California Los Angeles
Internship
- Internal Medicine & Pediatrics, University of California Los Angeles
Degree
- MD, Tufts University School of Medicine
My expertise
Specialties
- Diabetes
- Pediatrics
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221320%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221320%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 10 reviews
- January 29, 20265 out of 5 Stars
Dr. Kim was what every doctor should be. Thoughtful, informed, took the time to answer questions, explained things carefully and generally left me feeling like my near diabetes was something that we can tackle together and that I was in good hands.
- November 19, 20255 out of 5 Stars
Excellent physician In every way
- May 22, 20255 out of 5 Stars
Obviously I am very pleased with my experience at UCSF from front desk to Nurses to my Doctor
- April 4, 20255 out of 5 Stars
Dr. Sarah Kim is an outstanding doctor and communicator.
- February 25, 20255 out of 5 Stars
Absolutely, Dr. Kim is the BEST!!!
- February 4, 20255 out of 5 Stars
Dr. Kim is professional, knowledgeable, and empathetic. I can't recommend her highly enough.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.